within Pharmacolibrary.Drugs.D_Dermatologicals.D11A_OtherDermatologicalPreparations.D11AX05_MagnesiumSulfate;

model MagnesiumSulfate
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.3333333333333332e-06,
    adminDuration = 600,
    adminMass = 4000 / 1000000,
    adminCount = 1,
    Vd = 0.00025,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.0065,
    k12 = 8.611111111111112e-07,
    k21 = 8.611111111111112e-07);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>MagnesiumSulfate</td></tr><tr><td>ATC code:</td><td>D11AX05</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>4000</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.25</td><td>L</td></tr>
    <tr><td>clearance:</td><td>4.8</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Magnesium sulfate is an inorganic salt used primarily for its anticonvulsant properties in eclampsia and pre-eclampsia, as a tocolytic agent in preterm labor, and as a replacement therapy for hypomagnesemia. It is also used intravenously or intramuscularly for the management of arrhythmias and severe asthma exacerbations. Approved for medical use, especially in obstetric and emergency medicine settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients (including pregnant women) following intravenous administration; typically referenced from published population PK studies in critically ill patients.</p><h4>References</h4><ol><li><p>da Costa, TX, et al., &amp; Oliveira, AG (2020). Population Pharmacokinetics of Magnesium Sulfate in Preeclampsia and Associated Factors. <i>Drugs in R&amp;D</i> 20(3) 257–266. DOI:<a href=\"https://doi.org/10.1007/s40268-020-00315-2\">10.1007/s40268-020-00315-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32642964/\">https://pubmed.ncbi.nlm.nih.gov/32642964</a></p></li><li><p>Brookfield, KF, et al., &amp; Carvalho, B (2016). Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. <i>American journal of obstetrics and gynecology</i> 214(6) 737.e1–737.e7379. DOI:<a href=\"https://doi.org/10.1016/j.ajog.2015.12.060\">10.1016/j.ajog.2015.12.060</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26767791/\">https://pubmed.ncbi.nlm.nih.gov/26767791</a></p></li><li><p>Rower, JE, et al., &amp; Finkelstein, Y (2025). Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations. <i>Journal of clinical pharmacology</i> 65(6) 665–674. DOI:<a href=\"https://doi.org/10.1002/jcph.6179\">10.1002/jcph.6179</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39775569/\">https://pubmed.ncbi.nlm.nih.gov/39775569</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.D.D11AX05 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end MagnesiumSulfate;
